ImmunoPrecise Antibodies Ltd. (IPA)

NASDAQ: IPA · Real-Time Price · USD

0.8500

+0.1485 (21.17%)

At close: Jun 16, 2025, 4:00 PM

0.8000

-0.0500 (-5.88%)

Pre-market: Jun 17, 2025, 7:00 AM EDT

ImmunoPrecise Antibodies Income Statement

Financials in millions CAD. Fiscal year is May - April.

Millions CAD. Fiscal year is May - Apr.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Jan '25 Jan 31, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021	Apr '20 Apr 30, 2020	2015 - 2019
Revenue	24	24.52	20.67	19.36	17.91	14.06	Upgrade
Revenue Growth (YoY)	1.34%	18.64%	6.72%	8.11%	27.41%	28.66%	Upgrade
Cost of Revenue	11.8	12.47	9.1	8.38	6.51	6.1	Upgrade
Gross Profit	12.2	12.05	11.56	10.98	11.4	7.95	Upgrade
Selling, General & Admin	19.32	19.14	18.19	18.06	10.59	8.24	Upgrade
Research & Development	5.11	4.04	14.1	7.66	1.97	0.45	Upgrade
Operating Expenses	26.98	26.15	36.71	27.73	18.06	12.05	Upgrade
Operating Income	-14.78	-14.09	-25.14	-16.75	-6.65	-4.09	Upgrade
Interest Expense	-0.31	-0.02	-0	-0.09	-0.64	-0.7	Upgrade
Interest & Investment Income	-	0.02	0.12	0.28	0.28	0.05	Upgrade
Currency Exchange Gain (Loss)	-0.09	0.09	0.23	0.63	-1.23	0.08	Upgrade
Other Non Operating Income (Expenses)	0.2	0.33	0.31	0.08	-0.22	-0.73	Upgrade
EBT Excluding Unusual Items	-14.98	-13.67	-24.49	-15.85	-8.47	-5.4	Upgrade
Merger & Restructuring Charges	-	-	-0.8	-	-	-	Upgrade
Impairment of Goodwill	-11.16	-11.16	-2.46	-	-	-	Upgrade
Asset Writedown	-25.05	-3.87	-	-	-	-	Upgrade
Other Unusual Items	-	-	-	-	2.47	0.11	Upgrade
Pretax Income	-51.19	-28.7	-27.75	-15.85	-6	-5.29	Upgrade
Income Tax Expense	-4.45	-1.53	-1.19	0.86	1.35	-0.35	Upgrade
Net Income	-46.75	-27.18	-26.56	-16.71	-7.34	-4.95	Upgrade
Net Income to Common	-46.75	-27.18	-26.56	-16.71	-7.34	-4.95	Upgrade
Shares Outstanding (Basic)	29	26	25	20	16	14	Upgrade
Shares Outstanding (Diluted)	29	26	25	20	16	14	Upgrade
Shares Change (YoY)	13.70%	2.97%	26.46%	19.51%	20.88%	8.67%	Upgrade
EPS (Basic)	-1.63	-1.06	-1.07	-0.85	-0.45	-0.36	Upgrade
EPS (Diluted)	-1.63	-1.06	-1.07	-0.85	-0.45	-0.36	Upgrade
Free Cash Flow	-9.48	-5.64	-21.33	-10.99	-2.03	-1.85	Upgrade
Free Cash Flow Per Share	-0.33	-0.22	-0.86	-0.56	-0.12	-0.14	Upgrade
Gross Margin	50.82%	49.16%	55.95%	56.72%	63.67%	56.58%	Upgrade
Operating Margin	-61.60%	-57.48%	-121.67%	-86.49%	-37.14%	-29.12%	Upgrade
Profit Margin	-194.79%	-110.84%	-128.53%	-86.29%	-40.98%	-35.19%	Upgrade
Free Cash Flow Margin	-39.50%	-23.02%	-103.21%	-56.74%	-11.32%	-13.18%	Upgrade
EBITDA	-12.54	-10.37	-21.31	-12.98	-4.6	-2.39	Upgrade
EBITDA Margin	-52.26%	-42.30%	-103.11%	-67.03%	-25.66%	-16.99%	Upgrade
D&A For EBITDA	2.24	3.72	3.84	3.77	2.06	1.71	Upgrade
EBIT	-14.78	-14.09	-25.14	-16.75	-6.65	-4.09	Upgrade
EBIT Margin	-61.60%	-57.48%	-121.67%	-86.49%	-37.14%	-29.12%	Upgrade
Advertising Expenses	-	-	-	-	0.69	0.38	Upgrade

Updated Mar 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q